Sakhiya Skin Clinic, a dermatology-focused healthcare provider in India, provides skin, laser, anti-aging, hair, dermatological surgery and plastic surgery treatments, has served over 5,40,000 patients through its network of 35 clinics primarily operated in Gujarat and Maharashtra. It has filed a draft prospectus for Red Herring (DRHP) for its initial public offering (IPO).
DRHP outlines the total ticket price of up to 61,72,000 shares, including brand new stocks of up to 50,10,000 shares and quotes of up to 11,62,000 shares. As part of OFS, shareholder promoter and sale shareholder Jagdishkumar Jadavbhai Sakhiya plans to sell up to 8,82,653 shares, while Rupalben Jagdishbhai Sakhiya (also a promoter and seller of shareholders, can also sell 2,79,347 shares.
The proceeds from the fresh question are specifically used to open new clinics in India up to Rs 42,5733 crore, allocated specifically for this purpose for upgrading technology and facilities up to Rs 9,646 crore for investment in advanced science companies of its subsidiary Skakhiya Dr. Skinya for your skakhiya drag for scientific fortherife for Skiniary for The Ather Infectife for Skiniary for Reply for Rake for Rake for ins for Skiniary for Skiniary for ins for Skiniary for. Borrowing and balance towards general corporate purposes.
Add Zee business as your preferred source
In fiscal 2025, Saki Dermatology Clinic’s healthcare services revenue was Rs 528,778 crore, earning a profit of Rs 109,1669 crore with a profit margin of 20.6%. During the fiscal year, the clinic served approximately 1,48,192 patients, including 30,991 new patients. Its skin cosmetics clinic records nearly 1,00,000 patient visits each year on its network of 35 centers.
GYR Capital Advisors Private Limited is the only bookkeeping chief manager for the IPO.
This article comes from Brand Table. It is recommended that users take discretion.
